{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:49:04Z","timestamp":1741067344655,"version":"3.38.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.toxicon.2025.108276","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T07:42:49Z","timestamp":1738654969000},"page":"108276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High-dose rimabotulinumtoxinB for chronic sialorrhea: A case report on the safety and efficacy of 20,000 Units injection"],"prefix":"10.1016","volume":"256","author":[{"given":"Ali Zare","family":"Dehnavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Pedouim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Savica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khashayar","family":"Dashtipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.toxicon.2025.108276_bib1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.toxicon.2009.03.009","article-title":"NeuroBloc\/Myobloc: unique features and findings","volume":"54","author":"Arezzo","year":"2009","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.toxicon.2025.108276_bib2","first-page":"213","article-title":"A study of salivary secretion in Parkinson's disease","volume":"22","author":"Bagheri","year":"1999","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108276_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1469-8749.2011.03952.x","article-title":"Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses","volume":"53","author":"Basciani","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108276_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.23929","article-title":"Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial","volume":"27","author":"Chinnapongse","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2025.108276_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40734-017-0055-1","article-title":"RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials","volume":"4","author":"Dashtipour","year":"2017","journal-title":"J Clin Mov Disord"},{"issue":"1","key":"10.1016\/j.toxicon.2025.108276_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000067023","article-title":"Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis","volume":"49","author":"Dressler","year":"2003","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108276_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.toxicon.2025.108276_bib8","first-page":"2628","article-title":"Sialorrhea: a management challenge","volume":"69","author":"Hockstein","year":"2004","journal-title":"Am. Fam. Physician"},{"issue":"11","key":"10.1016\/j.toxicon.2025.108276_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12110691","article-title":"Sialorrhea in Parkinson's disease","volume":"12","author":"Isaacson","year":"2020","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.toxicon.2025.108276_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaneurol.2019.4565","article-title":"Safety and efficacy of RimabotulinumtoxinB for treatment of sialorrhea in adults: a randomized clinical trial","volume":"77","author":"Isaacson","year":"2020","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108276_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.toxicon.2025.108276_bib12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00415-009-5098-2","article-title":"Prevalence and definition of drooling in Parkinson's disease: a systematic review","volume":"256","author":"Kalf","year":"2009","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108276_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-009-0085-1","article-title":"Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling","volume":"256","author":"Lagalla","year":"2009","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108276_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.54.1.244","article-title":"Botulinum toxin A as treatment for drooling saliva in PD","volume":"54","author":"Pal","year":"2000","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.toxicon.2025.108276_bib15","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/mds.21752","article-title":"Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism","volume":"22","author":"Postma","year":"2007","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108276_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1517\/14656566.6.9.1551","article-title":"Controlling sialorrhoea: a review of available treatment options","volume":"6","author":"Potulska","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.toxicon.2025.108276_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jocn.2018.02.011","article-title":"Pharmacological interventions for treating sialorrhea associated with neurological disorders: a mixed treatment network meta-analysis of randomized controlled trials","volume":"51","author":"Sridharan","year":"2018","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108276_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-009-1689-y","article-title":"Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea","volume":"207","author":"Steinlechner","year":"2010","journal-title":"Psychopharmacology (Berl)."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108276_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ene.15083","article-title":"Efficacy and safety of botulinum toxin for treating sialorrhea: a systematic review and meta-analysis","volume":"29","author":"Yu","year":"2022","journal-title":"Eur. J. Neurol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010125000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T17:58:48Z","timestamp":1741024728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010125000509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":19,"alternative-id":["S0041010125000509"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108276","relation":{},"ISSN":["0041-0101"],"issn-type":[{"type":"print","value":"0041-0101"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose rimabotulinumtoxinB for chronic sialorrhea: A case report on the safety and efficacy of 20,000 Units injection","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108276"}}